Patents by Inventor Eva ALBERT

Eva ALBERT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9321777
    Abstract: The disclosure relates to compounds of formula (I): wherein , A, W, X, and Ra are as defined in the disclosure, and salts thereof, and to pharmaceutical compositions comprising said compounds, to processes for preparing them, and to their use as medicaments, in particular as MET inhibitors.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: April 26, 2016
    Assignee: SANOFI
    Inventors: Eva Albert, Eric Bacque, Conception Nemecek, Antonio Ugolini, Sylvie Wentzler
  • Publication number: 20150344484
    Abstract: The disclosure relates to compounds of formula (I): wherein , A, W, X, and Ra are as defined in the disclosure, and salts thereof, and to pharmaceutical compositions comprising said compounds, to processes for preparing them, and to their use as medicaments, in particular as MET inhibitors.
    Type: Application
    Filed: June 4, 2015
    Publication date: December 3, 2015
    Inventors: Eva ALBERT, Eric Bacque, Conception Nemecek, Antonio Ugolini, Sylvie Wentzler
  • Patent number: 9115134
    Abstract: The disclosure relates to compounds of formula (I): wherein , A, W, X, and Ra are as defined in the disclosure, and salts thereof, and to pharmaceutical compositions comprising said compounds, to processes for preparing them, and to their use as medicaments, in particular as MET inhibitors.
    Type: Grant
    Filed: August 27, 2013
    Date of Patent: August 25, 2015
    Assignee: SANOFI
    Inventors: Eva Albert, Eric Bacque, Conception Nemecek, Antonio Ugolini, Sylvie Wentzler
  • Publication number: 20140005189
    Abstract: The disclosure relates to compounds of formula (I): wherein , A, W, X, and Ra are as defined in the disclosure, and salts thereof, and to pharmaceutical compositions comprising said compounds, to processes for preparing them, and to their use as medicaments, in particular as MET inhibitors.
    Type: Application
    Filed: August 27, 2013
    Publication date: January 2, 2014
    Applicant: SANOFI
    Inventors: Eva Albert, Eric Bacque, Conception Nemecek, Antonio Ugolini, Sylvie Wentzler
  • Patent number: 8546393
    Abstract: The disclosure relates to compounds of formula (I): wherein , A, W, X, and Ra are as defined in the disclosure, and salts thereof, and to pharmaceutical compositions comprising said compounds, to processes for preparing them, and to their use as medicaments, in particular as MET inhibitors.
    Type: Grant
    Filed: January 26, 2010
    Date of Patent: October 1, 2013
    Assignee: Sanofi
    Inventors: Eva Albert, Eric Bacque, Conception Nemecek, Antonio Ugolini, Sylvie Wentzler
  • Publication number: 20100298315
    Abstract: The disclosure relates to compounds of formula (I): wherein , A, W, X, and Ra are as defined in the disclosure, and salts thereof, and to pharmaceutical compositions comprising said compounds, to processes for preparing them, and to their use as medicaments, in particular as MET inhibitors.
    Type: Application
    Filed: January 26, 2010
    Publication date: November 25, 2010
    Applicant: sanofi-aventis
    Inventors: Eva ALBERT, Eric BACQUE, Conception NEMECEK, Antonio UGOLINI, Sylvie WENTZLER